Home Healthcare Glaucoma Market
glaucoma market

Glaucoma Market, [By Product (Alpha Agonist, Beta Blockers, Cholinergic, Carbonic Anhydrase Inhibitors, Prostaglandin Analogues (PGAs)), By Surgery (Conventional Glaucoma Surgeries, and Minimal Invasive Glaucoma Surgeries); By Indication (Secondary Glaucoma, Angle Closure Glaucoma (ACG), Open Angle Glaucoma (OAG), Congenital Glaucoma, and Other Indications); By End Use (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacy Stores)]; and Geography - Trend, Analysis and Forecast till 2025

  • Published Date: Aug 2018
  • Pages: 0
  • Format: PDF
  • Report ID: PM1366
  • Base Year:
  • Historical Data:

Report Summary

The global glaucoma market is driven by the factors such as increasing geriatric population and increasing demand for the combination drugs by end users.

Glaucoma is the second most common leading cause of blindness and is commonly observed in the older population. This disease damages the optic nerve, which happens due to extra fluid that is built in front of eye, resulting in increased pressure on eye. Glaucoma is generally characterized by symptoms such as tunnel vision, eye pain, blurred vision, and red eyes.

The clear liquid that is present in and out of anterior chamber nourishes nearby tissue in the eye. Generally, there are two types of glaucoma namely; Primary open-angle glaucoma and angle-closure glaucoma. Primary open-angle glaucoma is the most common type of glaucoma which is found in the iris located very close to the drainage angle in the eye. The treatment of glaucoma majorly focuses on the improving fluid flow in the eyes or reducing its production. Majorly used eye drops include prostaglandin analogues, cholinergic agents, and beta blockers. Even though, with high adoption rate the eye drops have relative side effects that lead to chronic disorders like kidney stone, weight loss, impotence, and fatigue.

Increasing geriatric population and early diagnosis of glaucoma assist the growth of global glaucoma market

The growth in this market is primarily driven by the increasing number of fixed-dose combination that are used for treating glaucoma and increasing geriatric population.  Additionally, increasing awareness for diagnosis of glaucoma at the initial stage is also resulting in growth of this entire industry. Also, development of new phase drugs by the biopharmaceutical companies and government initiatives for supporting the drug development is expected to increase the market for glaucoma during the forecast period. Moreover, rapid technological advancements in the devices that are used in surgeries would also stimulate the growth of this market.

However, lack of awareness about glaucoma treatment by using various surgical devices across developing countries would impede the growth of global glaucoma market in the near future.

Global Glaucoma Market Taxonomy

The global glaucoma market is segmented on the basis of product, surgery, indication, and by end use and geography.

On the basis of product type, market is segmented as

  • Alpha Agonist
  • Beta Blockers
  • Cholinergic
  • Carbonic Anhydrase Inhibitors
  • Prostaglandin Analogues (PGAs)

On the basis of surgery type, market is segmented as

  • Conventional Glaucoma Surgery
  • Minimal Invasive Glaucoma Surgery

On the basis of indication type, market is segmented as

  • Secondary Glaucoma
  • Angle-Closure Glaucoma (ACG)
  • Open Angle Glaucoma (OAG)
  • Other

On the basis of end use type, market is segmented as

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacy Store

Geographically, the global glaucoma market is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Technological advancement & innovation of vaccines and favorable government policies to lead the growth of North America glaucoma market.

On the basis of geography, North America region is expected to dominate the global glaucoma market over the forecast period. The primary factor influencing growth of glaucoma market in this region is rise in observance of glaucoma among the increasing geriatric population. Additionally, availability of key manufacturers and heavy investment on research and development by the government towards glaucoma is expected to have a positive impact on the growth of glaucoma market in North America. On the other hand, increased awareness for the use of these drugs also promotes market growth in the near future. While, Europe region is observed to hold the second largest market share in this market.

However, Asia Pacific is observed to grow at a faster rate during forecast period. Increasing awareness for the use of new drugs, improving economic settings by the key payers for focussing on the untapped market, and growing government concern for promoting minimal invasive surgeries are the major factors resulting in growth of glaucoma market in Asia Pacific during upcoming years.

Key players in the global glaucoma market are:

  • Novartis AG
  • Allergan Inc.
  • Merck & Co.
  • Akron, Inc.
  • Bausch & Lomb Incorporated
  • Teva Pharmaceuticals
  • Pfizer Inc.
  • Santen
  • Aerie Pharmaceuticals
  • Inotek Pharmaceuticals
  • Essilor International SA
  • Hoya Corporation
  • Sonomed Escalon
  • Carl Zeiss Meditec AG
  • HumanOptics AG
Key Take-Away
Polaris Market Research
Glaucoma Market Size, Share, Analysis - Industry Forecast Report 2025